Table 4.16

Prevalence of self-reported use of tobacco products, of saliva cotinine of 15 ng/ml or over, and of adjusted tobacco use^a, by minority ethnic group^b

Aged 16 and over with a valid saliva cotinine measurement							1999
Use of tobacco products, saliva cotinine level, adjusted smoking prevalence	Minority ethnic group						General population (1998)c
	Black
Men	Caribbean	Indian	Pakistani	Bangladeshi	Chinese	Irish
Observed %
Self-reported use of any tobacco
products	38	28	28	53	20	44	32
Saliva cotinine level 15 ng/ml and over	40	29	35	55	18	40	32
Adjusted tobacco use prevalence	43	34	38	59	23	46	36
Extent of under-reporting	5	6	9	6	3	1	3
Standardised risk ratios
Adjusted smoking prevalence	1.23	0.89	0.97	1.52	0.53	1.34	1
Standard error	0.09	0.07	0.08	0.11	0.10	0.09
Women
Observed %
Self-reported use of any tobacco
products	25	8	7	27	9	33	27
Saliva cotinine level 15 ng/ml and over	26	10	10	34	9	33	27
Adjusted tobacco use prevalence	28	12	12	38	11	35	29
Extent of under-reporting	3	4	5	12	2	2	2
Standardised risk ratios
Adjusted smoking prevalence	0.86	0.38	0.31	1.75	0.28	1.09	1
Standard error	0.07	0.06	0.06	0.12	0.07	0.09
Bases (weighted):
Men	188	329	167	46	43	883	c
Women	251	298	162	43	53	968	c
Bases (unweighted):
Men	270	348	279	179	136	302	5042
Women	364	321	278	174	165	351	5468

^a Adjusted tobacco use prevalence is the proportion who reported tobacco product use and/or had saliva cotinine of 15 ng/ml or over.

^b An additional weight has been added to correct for response bias in the sub-sample providing a valid saliva sample (see Section 4.5.1).

^c Comparative general population data are not available for saliva cotinine from the 1999 survey itself, comparative data have therefore been taken from the 1998
survey, in which no weighting was involved.

We welcome your comments on this site. Prepared 10 January 2001